Literature DB >> 8876136

Epstein-Barr virus vectors for gene delivery to B lymphocytes.

E S Robertson1, T Ooka, E D Kieff.   

Abstract

Basic research in Epstein-Barr virus (EBV) molecular genetics has provided means to maintain episomes in human cells, to efficiently deliver episomes with up to 150 kbp of heterologous DNA to human B lymphocytes, and to immortalize human B lymphocytes with EBV recombinants that can maintain up to 120 kbp of heterologous DNA. Episome maintenance requires an EBV nuclear protein, EBNA1, whereas immortalization of cells with EBV recombinants requires EBNA1, EBNA2, EBNA3A, EBNA3C, EBNALP, and LMP1. EBV-derived vectors are useful for experimental genetic reconstitution in B lymphocytes, a cell type frequently used in establishing repositories of human genetic deficiencies. The ability of EBV-infected cells to establish a balanced state of persistence in normal humans raises the possibility that cells infected with EBV recombinants could be useful for genetic reconstitution, in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8876136      PMCID: PMC38058          DOI: 10.1073/pnas.93.21.11334

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Epstein-Barr virus recombinants with specifically mutated BCRF1 genes.

Authors:  S Swaminathan; R Hesselton; J Sullivan; E Kieff
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

2.  Reducing the complexity of the transforming Epstein-Barr virus genome to 64 kilobase pairs.

Authors:  E Robertson; E Kieff
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

Review 3.  Genes for SMA: multum in parvo.

Authors:  B Lewin
Journal:  Cell       Date:  1995-01-13       Impact factor: 41.582

4.  Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa.

Authors:  E S Robertson; S Grossman; E Johannsen; C Miller; J Lin; B Tomkinson; E Kieff
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

5.  An Epstein-Barr virus with a 58-kilobase-pair deletion that includes BARF0 transforms B lymphocytes in vitro.

Authors:  E S Robertson; B Tomkinson; E Kieff
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

6.  Genetic and biochemical evidence that EBNA 2 interaction with a 63-kDa cellular GTG-binding protein is essential for B lymphocyte growth transformation by EBV.

Authors:  R Yalamanchili; X Tong; S Grossman; E Johannsen; G Mosialos; E Kieff
Journal:  Virology       Date:  1994-11-01       Impact factor: 3.616

7.  The lytic cycle of Epstein-Barr virus in the nonproducer Raji line can be rescued by the expression of a 135-kilodalton protein encoded by the BALF2 open reading frame.

Authors:  G Decaussin; V Leclerc; T Ooka
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

8.  Tap-1 and Tap-2 gene therapy selectively restores conformationally dependent HLA Class I expression in type I diabetic cells.

Authors:  F Wang; X Li; B Annis; D L Faustman
Journal:  Hum Gene Ther       Date:  1995-08       Impact factor: 5.695

9.  The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation; fibroblast cocultivation complements a critical function within the terminal 155 residues.

Authors:  K M Kaye; K M Izumi; G Mosialos; E Kieff
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

10.  Immortalization of human B lymphocytes by a plasmid containing 71 kilobase pairs of Epstein-Barr virus DNA.

Authors:  B Kempkes; D Pich; R Zeidler; B Sugden; W Hammerschmidt
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

View more
  16 in total

1.  Structural, functional, and genetic comparisons of Epstein-Barr virus nuclear antigen 3A, 3B, and 3C homologues encoded by the rhesus lymphocryptovirus.

Authors:  H Jiang; Y G Cho; F Wang
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Epstein-Barr virus recombinants from BC-1 and BC-2 can immortalize human primary B lymphocytes with different levels of efficiency and in the absence of coinfection by Kaposi's sarcoma-associated herpesvirus.

Authors:  A J Aguirre; E S Robertson
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 3.  Viral vectors for gene delivery to the central nervous system.

Authors:  Thomas B Lentz; Steven J Gray; R Jude Samulski
Journal:  Neurobiol Dis       Date:  2011-10-07       Impact factor: 5.996

4.  The ID proteins contribute to the growth of rodent fibroblasts during LMP1-mediated transformation.

Authors:  David N Everly; Bernardo A Mainou; Nancy Raab-Traub
Journal:  Virology       Date:  2008-05-05       Impact factor: 3.616

Review 5.  Phylogenetic comparison of Epstein-Barr virus genomes.

Authors:  Su Jin Choi; Seok Won Jung; Sora Huh; Hyosun Cho; Hyojeung Kang
Journal:  J Microbiol       Date:  2018-06-14       Impact factor: 3.422

6.  Epstein-Barr virus nuclear protein 3C binds to the N-terminal (NTD) and beta trefoil domains (BTD) of RBP/CSL; only the NTD interaction is essential for lymphoblastoid cell growth.

Authors:  Michael A Calderwood; Sungwook Lee; Amy M Holthaus; Stephen C Blacklow; Elliott Kieff; Eric Johannsen
Journal:  Virology       Date:  2011-03-26       Impact factor: 3.616

7.  An Epstein-Barr virus isolated from a lymphoblastoid cell line has a 16-kilobase-pair deletion which includes gp350 and the Epstein-Barr virus nuclear antigen 3A.

Authors:  W Lee; Y H Hwang; S K Lee; C Subramanian; E S Robertson
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

8.  Analysis of EBNA-1 and LMP-1 variants in diseases associated with EBV infection in Chinese children.

Authors:  Junhong Ai; Zhengde Xie; Chunyan Liu; Zhizuo Huang; Junmei Xu
Journal:  Virol J       Date:  2012-01-11       Impact factor: 4.099

Review 9.  Mesenchymal Stem/Progenitor Cells: The Prospect of Human Clinical Translation.

Authors:  Dina Rady; Marwa M S Abbass; Aiah A El-Rashidy; Sara El Moshy; Israa Ahmed Radwan; Christof E Dörfer; Karim M Fawzy El-Sayed
Journal:  Stem Cells Int       Date:  2020-08-11       Impact factor: 5.443

10.  A Genome-Wide Epstein-Barr Virus Polyadenylation Map and Its Antisense RNA to EBNA.

Authors:  Vladimir Majerciak; Wenjing Yang; Jing Zheng; Jun Zhu; Zhi-Ming Zheng
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.